Oral Micronized Progesterone Cost vs. Alternatives in Class

How Oral Micronized Progesterone Works

Oral micronized progesterone is bioidentical to the progesterone produced by the corpus luteum. It binds progesterone receptors in the endometrium, converting proliferative tissue to a secretory state and preventing the unopposed-estrogen-driven hyperplasia that raises endometrial cancer risk. The micronization process reduces particle size to 5 to 10 micrometers, improving intestinal absorption of an otherwise poorly bioavailable steroid 1.

Pharmacokinetics and Metabolism

After oral dosing, progesterone undergoes extensive first-pass hepatic metabolism, producing the neuroactive metabolite allopregnanolone. This metabolite acts on GABA-A receptors, which explains the mild sedation many women report at bedtime. Peak serum progesterone concentrations occur 2 to 4 hours after a 200 mg dose taken with food, and the elimination half-life ranges from 16 to 18 hours 2. Taking the capsule with a high-fat meal increases bioavailability by approximately 25%, per the FDA-approved Prometrium labeling 3.

Why Micronization Matters

Non-micronized progesterone dissolves poorly in gastrointestinal fluid. Micronization suspends the hormone in peanut oil within a gelatin capsule, raising oral bioavailability from near-negligible levels to clinically effective concentrations. Without this formulation step, oral progesterone would require impractically high doses.

Cost Breakdown: OMP at Retail and With Insurance

A 30-day supply of generic micronized progesterone 100 mg capsules runs $25 to $60 at most U.S. Retail pharmacies, depending on chain and geography. The 200 mg strength, often used in cyclic 12-to-14-day regimens, costs $35 to $85 for 12 to 14 capsules per cycle. Brand-name Prometrium is markedly more expensive at $150 to $300+ per month, though few prescribers write for the brand when generics are available 4.

Insurance Tiering

Most commercial formularies place generic OMP on Tier 1 (preferred generic) with copays of $0 to $15. Medicare Part D plans typically cover it under the generic tier as well. Prior authorization is rarely required because OMP carries a straightforward FDA indication for endometrial protection during estrogen therapy.

Pharmacy Discount Programs

GoodRx, RxSaver, and similar aggregators frequently list generic OMP 100 mg (30 capsules) below $30. Cash-pay patients who cannot access insurance coverage can often fill a 90-day supply through mail-order pharmacies for $50 to $80, reducing the per-month cost further.

Head-to-Head Cost Comparison With Alternatives

The table below compares the five most commonly prescribed progestational agents used for endometrial protection during menopausal hormone therapy, using average retail cash prices as of early 2026.

| Agent | Typical Monthly Cost (Generic, Cash) | Route | FDA-Approved for Endometrial Protection | |---|---|---|---| | Micronized progesterone (OMP) | $25 to $60 | Oral | Yes | | Medroxyprogesterone acetate (MPA / Provera) | $4 to $15 | Oral | Yes | | Norethindrone acetate (NETA) | $15 to $40 | Oral | Yes (in combination products) | | Levonorgestrel IUD (Mirena) | $15 to $22/mo amortized | Intrauterine | Off-label for HRT | | Compounded progesterone | $30 to $80 | Oral or topical | No (not FDA-approved) |

MPA is the cheapest option by a wide margin. But cost is only one variable.

Where the Extra Dollars Go

The price premium of OMP over MPA buys a measurable lipid advantage. In the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875), women randomized to conjugated equine estrogen plus micronized progesterone experienced a 4.1 mg/dL increase in HDL cholesterol at 36 months, while those on conjugated equine estrogen plus MPA saw no meaningful HDL rise 1. For women with borderline dyslipidemia already managing cardiovascular risk factors, that difference may justify the additional $15 to $45 per month.

OMP vs. Medroxyprogesterone Acetate (Provera)

MPA remains the most prescribed synthetic progestin in the United States, largely because of its low cost and decades of clinical familiarity. A 30-day supply of generic MPA 2.5 mg costs as little as $4 at some pharmacies. That price gap is significant for uninsured patients.

Clinical Tradeoffs

Both agents provide equivalent endometrial protection when dosed appropriately. The PEPI trial confirmed that OMP 200 mg given cyclically (days 1 through 12 of each month) and MPA 10 mg cyclically both prevented endometrial hyperplasia over three years, with hyperplasia rates below 1% in both groups vs. 34% in the unopposed estrogen arm 1.

The clinically relevant difference is metabolic. MPA blunts the HDL-raising effect of estrogen therapy. A secondary analysis of the Women's Health Initiative showed that the estrogen-plus-MPA arm had a higher incidence of coronary events than the estrogen-alone arm, though the relationship between MPA and cardiovascular risk remains debated 5.

Tolerability

OMP causes drowsiness in roughly 8% to 10% of users, which is why prescribers recommend bedtime dosing. MPA does not produce this effect but has been associated with greater rates of breast tenderness and mood changes in observational data. The E3N cohort study (N=80,377) found that women using estrogen plus micronized progesterone had no significant increase in breast cancer risk (RR 1.00, 95% CI 0.83 to 1.22) over a mean 8.1-year follow-up, while those using estrogen plus synthetic progestins showed a relative risk of 1.69 6.

OMP vs. Norethindrone Acetate

Norethindrone acetate (NETA) costs $15 to $40 monthly for the standalone 5 mg tablet. It is also available in fixed-dose combination pills with estradiol (Activella, Loestrin-type formulations), which can cost $30 to $90 per month for generics.

Clinical Profile

NETA is a 19-nortestosterone derivative with mild androgenic properties. It provides reliable endometrial suppression at doses of 0.5 to 1 mg daily (in combination products) or 5 mg cyclically. The androgenic activity means NETA may worsen acne or hirsutism in susceptible women, a side effect OMP does not share 7.

Cost Calculus

When NETA is prescribed as part of a fixed combination with estradiol, the total monthly cost for HRT can be lower than buying separate estradiol and OMP prescriptions. A generic estradiol/norethindrone acetate tablet costs $20 to $45 monthly, while generic estradiol ($10 to $25) plus generic OMP ($25 to $60) totals $35 to $85. The combination approach saves $10 to $40 per month for patients who do not have a clinical reason to prefer OMP.

OMP vs. Levonorgestrel IUD (Mirena) for Endometrial Protection

The 52 mg levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena) is used off-label for endometrial protection during systemic estrogen therapy. Its upfront cost is $900 to $1,300, but amortized over the 5-year FDA-approved duration, the monthly cost falls to roughly $15 to $22.

Efficacy Comparison

A randomized trial by Suvanto-Luukkonen et al. (N=32) found that the LNG-IUS produced endometrial atrophy in 100% of users at 12 months, compared with secretory or inactive endometrium in women on cyclic OMP 8. Larger observational studies support the IUD's effectiveness for endometrial suppression during HRT, though no definitive large RCT has compared the two agents head-to-head for this specific indication.

Who Benefits Most From the IUD Route

Women who also need contraception (in late perimenopause), those who experience GI side effects from oral progesterone, and patients with poor medication adherence are strong candidates for the LNG-IUS. The American College of Obstetricians and Gynecologists notes the LNG-IUS as an option for endometrial protection, though it remains off-label for this use 9.

Cost Barrier

The IUD requires an office visit for insertion, which adds $150 to $350 to the total cost depending on the provider and insurance coverage. For women without insurance, the combined device-plus-insertion cost of $1,050 to $1,650 can be prohibitive, even though the long-term amortized cost is competitive.

OMP vs. Compounded Progesterone

Compounded progesterone capsules, creams, and troches are marketed by compounding pharmacies at prices ranging from $30 to $80 per month. Some formulations are significantly more expensive.

The Quality and Regulation Gap

The FDA does not approve compounded hormone preparations, and they are not subject to the same bioequivalence testing as commercially manufactured generics. A 2001 FDA survey found that 34% of compounded products failed potency or content uniformity tests 10. The Endocrine Society and the American College of Obstetricians and Gynecologists both recommend FDA-approved hormone products over compounded versions when an approved option exists 9.

When Compounding Makes Sense

Patients with peanut oil allergy cannot take Prometrium or its generics (which use peanut oil as a vehicle). A compounded OMP capsule using an alternative oil base is a reasonable workaround, though the prescriber should verify the pharmacy holds USP <795> and <797> compliance certifications. Compounding is also appropriate for doses not commercially available, such as 50 mg or 150 mg.

Choosing Based on Clinical Context, Not Just Price

The 2022 Endocrine Society clinical practice guideline on menopausal hormone therapy states: "Micronized progesterone is preferred over medroxyprogesterone acetate for women with dyslipidemia or those concerned about breast cancer risk" 11. Dr. JoAnn Manson, chief of preventive medicine at Brigham and Women's Hospital and a principal WHI investigator, has noted that "the type of progestogen matters, and micronized progesterone appears to have a more favorable safety profile for cardiovascular and breast outcomes than synthetic progestins" 5.

A Decision Framework by Patient Profile

• Low-budget, no cardiovascular concerns: Generic MPA at $4 to $15/month provides effective endometrial protection at the lowest cost.
• Dyslipidemia or cardiovascular risk factors: Generic OMP preserves HDL benefits of estrogen therapy. The $15 to $45/month premium over MPA is clinically justified.
• Breast cancer risk prioritization: OMP shows a more favorable signal in observational data (E3N cohort, RR 1.00 vs. 1.69 for synthetic progestins) 6.
• Adherence challenges or need for contraception: Levonorgestrel IUD offers set-and-forget endometrial suppression, cost-effective over 5 years.
• Peanut allergy: Compounded OMP in an alternative oil base, sourced from a <795>-compliant pharmacy.

The North American Menopause Society's 2022 position statement supports individualized progestogen selection based on the patient's metabolic profile, breast cancer risk, and tolerance of side effects 12.

Insurance Navigation Tips for OMP

Generic OMP is covered by the vast majority of commercial and government payers. Patients who face formulary restrictions should ask their prescriber to submit a prior authorization citing the PEPI trial data on HDL preservation 1.

Step Therapy Workarounds

Some plans require a trial of MPA before covering OMP. If MPA causes intolerable mood symptoms or if the patient has documented dyslipidemia, a letter of medical necessity citing the lipid data from PEPI is usually sufficient to override step therapy.

Manufacturer Savings

Solvay (now AbbVie) previously offered a Prometrium savings card, but with multiple generics on the market, brand-name savings programs have become less relevant. Patients paying cash should compare prices across at least three pharmacies, as pricing variation for generic OMP can exceed 100% within the same zip code.

Generic micronized progesterone 100 mg, 30 capsules, filled at a mail-order pharmacy with a discount coupon, averages $22 to $28 nationally.